All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Armetheon Inc., of Milpitas, Calif., said data from a phase I trial of tecarfarin in severe chronic kidney (CKD) disease patients who require anticoagulation treatment showed good results.